WSA
ABBV icon

Wealth Science Advisors’s AbbVie ABBV Stock Holding History

Wealth Science Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$810K Buy
3,220
+523
+19% +$113K 0.36% 44
2026
Q1 		$616K Hold
2,697
– – 0.35% 30
2025
Q4 		$616K Buy
+2,697
New +$614K 0.36% 30

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Wealth Science Advisors's ABBV Position: Q2 2026 in Review

Wealth Science Advisors increased its AbbVie (ABBV) stake by 19% in Q2 2026, buying an estimated $113K and bringing the position to 3,220 shares worth $810K. The position accounts for 0.36% of the portfolio, ranked #44.

Wealth Science Advisors first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wealth Science Advisors held 3,220 shares of AbbVie worth $810K as of Q2 2026.
  • Wealth Science Advisors bought 523 AbbVie shares in Q2 2026, an estimated $113K.
  • AbbVie made up 0.36% of Wealth Science Advisors's portfolio in Q2 2026, its #44 holding.
  • Wealth Science Advisors first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealth Science Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.